Protocol for Eslax Intravenous Drug Use Investigation (Study P06082)

CompletedOBSERVATIONAL
Enrollment

3,969

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Anesthesia
Interventions
DRUG

Rocuronium

Normally, for adults, 0.6 mg/kg of rocuronium bromide is intravenously administered to support endotracheal intubation. If additional administration is necessary, 0.1 - 0.2 mg/kg is intravenously administered. In the case of continuous infusion, infusion is initiated at a rate of 7 μg/kg/min. Dosage should be adjusted based on the age or symptom. The upper limit of this drug for the intubation is 0.9 mg/kg.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00902070 - Protocol for Eslax Intravenous Drug Use Investigation (Study P06082) | Biotech Hunter | Biotech Hunter